I have been busy lately but found some time to go through an interesting story and a good article published in scientist magazine
- Father-in-law of now-infamous extensively drug-resistant TB patient studies tuberculosis at the CDC, and is now under review by the agency
- Genotyping with PCR -How to choose the right approach
I am working on an article about consolidation in Microarray and Bioinformatics industry so interesting to know about GenoLogics Announces Bioinformatics Partnership with Illumina so is the news of Roche acquiring Nimblgen and the end of patent wars with Affymetrix, Roche has also acquired 454 life sciences, It seems Roche plans to get inot clinical genomcis and theranostics application industry, the company already has FDA approved amplichip CYP450 arrays for clinical diagnostics
With many other acquisitions in the last one year and many more in the pipeline it seems paydays for early starters.
Filed under: bioinformatics blog, clinical diagnostics, clinical microarray, diagnostic microarray, DNA diagnostics, DNA medicine, microarray blog, microarray business, personalized medicine, Theranostics | Leave a comment »